Results 181 to 190 of about 629,305 (401)

The Prevalence and Implications of Polypharmacy in Individuals With Type 1 Diabetes

Clinical Pharmacology &Therapeutics, EarlyView.
Polypharmacy is increasingly recognized as a relevant issue in diabetes care, but its prevalence and clinical relevance in individuals with type 1 diabetes remain underexplored. This study aimed to determine the prevalence of polypharmacy and to identify associated clinical and psychological factors. Participants were recruited from a tertiary diabetes
Namam Ali, Stephan van Erp, Cornelis Kramers, Cornelis J. Tack, Bastiaan E. de Galan   +4 more
wiley   +1 more source

No evidence for additional systemic eosinophil mobilization during exacerbations in patients with COPD and chronic bronchitis but no allergy

Frontiers in Medicine
BackgroundThere is published evidence that a modest increase in blood eosinophils during stable COPD indicates future risk for exacerbations and a potential utility of inhaled corticosteroids. This has been perceived as an argument for targeting systemic
Anders Andersson, Anders Andersson, Kristina Andelid, Kristina Andelid, Bettina Brundin, Ann Ekberg-Jansson, Ann Ekberg-Jansson, Anders Lindén, Anders Lindén   +8 more
doaj   +1 more source

Investigation of Lung Sounds Features for Detection of Bronchitis and COPD Using Machine Learning Methods

, 2021
Hanna Porieva, Kateryna Ivanko, C. I. Semkiv, Valentyn Vaityshyn   +3 more
openalex   +1 more source

ERS International Congress, Madrid, 2019: highlights from the Airway Diseases, Asthma and COPD Assembly [PDF]

, 2020
Lies Lahousse, Thomas Bahmer, Sara Cuevas Ocaña, Pauline Flajolet, Alexander G. Mathioudakis, Melissa J. McDonnell, Lena Uller, Florence Schleich, Sérgio Duarte Dortas, Marco Idzko, Dave Singh, Fabio Luigi Massimo Ricciardolo, Ian M. Adcock, Omar S. Usmani, Antonio Spanevello, Sara J. Bonvini   +15 more
openalex   +1 more source

Once‐Daily Single‐Inhaler Triple versus Dual Therapy in Patients with COPD

New England Journal of Medicine, 2018
D. Lipson, F. Barnhart, N. Brealey, Jean Brooks, G. Criner, Nicola C. Day, M. Dransfield, D. Halpin, M. Han, Elaine C. Jones, S. Kilbride, P. Lange, D. Lomas, F. Martinez, Dave Singh, M. Tabberer, R. Wise, S. Pascoe   +17 more
semanticscholar   +1 more source

Cardiovascular Risk of Romosozumab vs. Teriparatide: A Cohort Study Using Japan’s National Claims Database

Clinical Pharmacology &Therapeutics, EarlyView.
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama, Eiko Iwasa, Shinya Watanabe, Tomoaki Hasegawa, Kazuhiro Kajiyama, Taihei Tanaka   +5 more
wiley   +1 more source

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box

ERJ Open Research, 2019
Lowie E.G.W. Vanfleteren, Anders Ullman, Anita Nordenson, Anders Andersson, Kristina Andelid, Leonardo M. Fabbri   +5 more
doaj   +1 more source

Remote monitoring of patients with COPD disease using a tablet system: a randomised crossover study of quality-of-life measurements

ERJ Open Research
Background Remote patient monitoring (RPM) has been evaluated in COPD, but with varying results. We aimed to evaluate whether a tablet system that monitors disease-related parameters in patients with COPD could influence physical and mental health ...
Malte Frerichs, Huiqi Li, Anders Andersson, Kristina Andelid, Monica Crona, Lowie E.G.W. Vanfleteren   +5 more
doaj   +1 more source

Spotlight commentary: Addressing the persistent problem of benzodiazepine overuse, time for clinical, educational and AI‐driven reform

British Journal of Clinical Pharmacology, EarlyView.
Jakša Vukojević, Luka Horvat, Vito Papić, Andrija Štajduhar   +3 more
wiley   +1 more source

Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 799-808, April 2025.
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu, Zhenbang Gu, Wengen Zhu, Shenghui Feng   +3 more
wiley   +1 more source